期刊名称：CTS-CLINICAL AND TRANSLATIONAL SCIENCE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
CTS: Clinical and Translational Science is your source for the most current and thought provoking original research across the broad spectrum of clinical specialties and basic science. CTS highlights investigative work bridging the gap between laboratory discovery and practice.
As a reader, you will have immediate access to original research, didactic reviews, expert analysis, commentary and educational reviews. This peer-reviewed journal helps you understand the rich and complex world that is such a part of translational medicine. Bonus features of the journal include: Community New, Views and Commentary including Up-Dates from the NIH, Insights into Regulatory Concerns, Contrasting Views and Expert Opinions that help you understand how to use the research in your practice.
Types of articles featured in CTS include:
Original Research Articles consist of comprehensive evaluations of a novel and important clinical or translational research hypothesis.
Communications: Review and Shorter Research Articles
Review articles survey recent developments in translational medicine including related basic and clinical science. Communications consists of a novel research result that is less extensive than an original research article.
Brief Reports provide information about a concise study that has important implications for the field.
Letters regarding a published article or interesting case in translational medicine that are sent to the Editor-in Chief.
Community News, Views & Commentary feature expert views.
Updates from the National Institutes of Health provide quick access to key actions and agenda items from translational-related subcommittees and policy decisions.
Insights feature expert commentary, identifying some of the new issues and challenges translational medicine tends to create for regulatory agencies.
CTSA Profile features news, views, and advice from a new Clinical and Translational Science Awardee in each issue.
Editorials, written by the Editor-in-Chief, discuss a wide range of topics including current issues, article commentary, and the state of translational medicine.
Controversy offers expert perspectives and opposing viewpoints on the many hot topics encompassed in this vibrant field.
Technical Reports review new techniques and technology that are likely to have an impact on translational research or the development of clinical research.
Statistical Discussion reviews new, complex, or controversial use of statistics and/or study design.
Background Basic Science provides clear, process-oriented description and reviews of the basic mechanisms and science behind a major original research article.
Highlighting Innovation spotlights innovative training, research, methods, or other related areas.
Commentary, invited by the Editor-in-Chief, offer a subject expert's perspective on featured articles, current state of the field, or specific topics.
Indexed / Abstracted in
Academic Search (EBSCO)
Biological Abstracts (Thomson ISI)
BIOSIS Previews (Thomson ISI)
MEDLINE/PubMed (NLM)
Science Citation Index Expanded™ (Thomson ISI)
SCOPUS (Elsevier)
Web of Science (Thomson ISI)
Instructions to Authors
Clinical and Translational Science (CTS) provides a forum for the publication of original research across the broad spectrum of medical sub-specialties and basic science. CTS highlights work that helps bridge laboratory discovery with the diagnosis and treatment of human disease. All research articles appear as Full Reports, Communications, or Brief Reports. CTS includes didactic reviews, commentaries, and editorials related to the field of translational medicine; the majority of these communications are solicited by the Editors. Readers will also find expert opinions, insights, and educational reviews that provide further insights into some of the rich complexity that is so much a part of translational medicine. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. These features have proven valuable to those practicing translational medicine as well as those seeking more information on this area, including specialty-based clinicians, researchers in a variety of settings, key personnel in government and industry, residents, fellows, and postdoctoral candidates.
Clinical and Translational Science is a peer-reviewed journal. All manuscripts will be reviewed by leaders in the appropriate field. Articles from the Editor's institution are processed by a guest editor.
The National Library of Medicine's official abbreviation for CTS is Clin Transl Sci.
ONLINE SUBMISSION
CTS requires that all manuscripts be submitted online at http://mc.manuscriptcentral.com/cts. Complete, detailed instructions on uploading your manuscript are available on this website. Any major word processing software, on either a Windows or a Macintosh platform, is acceptable for preparation of the manuscript. The main text of the document, figures, and tables should be submitted to the site as separate files in the standard document format of the word processing program used. (Please do not submit any manuscript material in PDF format.)
Authors should list a maximum of four suggested reviewers in the applicable field at the time of submission.
Please note: Manuscripts accepted for publication must be uploaded in an electronic format that is acceptable for print reproduction and typesetting purposes, in either a .doc or .txt file. Corresponding figures need to be formatted as either TIFF or EPS files. JPG, PDF, PPT, and PS files will not be accepted.
Please direct any questions to Arthur M. Feldman, MD, PhD, CTS, c/o Thomas Jefferson University, Dept. of Medicine, 1025 Walnut St, Rm 822, Philadelphia, PA 19107 USA. Phone: 215-955-6946; Fax: 215-955-2318; Email: arthur.feldman@jefferson.edu.
MANUSCRIPT PREPARATION
CTS organizes information into two major sections: 'Research Articles' and a section located in the front of the publication devoted to community news, view, and commentary.
Manuscript text should be double-spaced, and in a 12-point font. No columns. Each page should be numbered, beginning with the title page, and formatted with 1" margins.
Please be sure to specify directly on your manuscript complete funding details, including funding body name and grant number, for all relevant grants used to support the research on which your article is based.
Featured Articles
· Original Research Articles consist of comprehensive evaluations of a novel and important clinical or translational research hypothesis. Papers are limited to no more than 6,000 words, a maximum of 8 figures and/or tables, and 50 references. Each paper will have an abstract of no more than 200 words.
· Review Articles survey recent developments in a particular field. Papers are limited to no more than 2,500 words, with 6 figures and/or tables, and 100 references. In most cases, review articles will be solicited by a member of the Editorial Board. Therefore, it is suggested that individuals who have not had articles solicited send a brief summary of the proposed review to the editorial office prior to a full submission. Each paper will have an abstract of no more than 200 words.
· Communications consist of a novel research result that is less extensive than an original research article. The complete manuscript will consist of no more than 2,500 words, 6 figures and/or tables, and 25 references. Each paper will have an abstract of no more than 200 words.
· Brief Reports provide information about a concise study that has important implications for the field. The text will consist of no more than 1,000 words and be accompanied by a single figure or table, with no more than 10 references. Each paper will have an abstract of no more than 200 words.
· Preliminary Reports describe a study with a small sample population with results that may encourage further investigation. The text will consist of no more than 2,500 words, 8 figures and/or tables, and 30 references. Each paper will have an abstract of no more than 200 words.
· Background Basic Science articles will describe and review the basic mechanisms/science behind a major original research article. These pieces will have no more than 2,500 words with up to 5 figures and/or tables and 5 references. Each paper will have an abstract of no more than 200 words.
· Letters regarding a published article may be sent to the Editor-in-Chief. Letters will be reviewed and are subject to editing. If accepted for publication, a copy of the letter will be sent to the author(s) of the original article, if applicable. The author(s) will have an opportunity to respond with new material that will be considered for publication with the letter. The text will consist of no more than 250 words and no more than 5 references. No abstract is required.
Community News, Views and Commentary
Articles in this area feature expert views, often invited by the editor but open for manuscript submission. These features do not require abstracts.
· Commentary in a variety of areas are invited by the Editor-in-Chief and will offer a subject expert's perspective on a topic. This type of article will be limited to 2,500 words and 2 figures or tables.
· Updates: NIH provide quick access to key actions and agenda items from translational-related subcommittees and overall policy decisions that may affect translational medicine.
· Updates: FDA offer news regarding administration policy decisions and their possible consequences for translational medicine.
· Profile: CTSA features news, views, and advice from a new Clinical and Translational Science Award recipient in each issue.
· Special Reports document a program or policy pertaining to translational medicine and suggest models for best practice in the field.
For all article types listed above, the manuscript should consist of the following, unless otherwise specified:
· Title Page: Please include a brief, descriptive title of the article, as well as a short title of fewer than 50 characters; each author's full name, highest academic degree, and hospital and academic affiliations; acknowledgement of ALL sources of financial support; and the name, address, phone and fax numbers, and email address of the individual responsible for editorial correspondence and reprint requests.
· Abstract: Include a brief abstract (without references) of no more than 200 words for Original Research, Review Articles, Communications, Brief Reports, Preliminary Reports, and Background Basic Science articles. Letters and Community News, Views and Commentary features do not require an abstract. Avoid all abbreviations other than standard units of measurement. Use generic names of drugs.
· Text: Organize into sections--Introduction, Methods, Results, Discussion, and Conclusion--with appropriate subheadings to make the sections easily understood. Explain abbreviations at first mention, followed by the abbreviations in parentheses, and limit use only to a few commonly accepted words. References, tables, and figures should be cited in numerical order. Avoid jargon, clichés, and laboratory slang. Place acknowledgements at the end of the text, before references. Authors whose native language is not English are strongly advised to seek appropriate grammatical assistance. Suggested English language editing services can be found athttp://authorservices.wiley.com//bauthor/english_language.asp.
· References: Include references to unpublished material or personal communications in the text parentheses. Number all published references in the order in which they are cited in the text. Abbreviate titles of periodicals according to the style of Index Medicus, National Library of Medicine. List all authors in each reference following exactly the format and punctuation shown below--do NOT use 'et al.' Note that CTS follows AMA style.
(a) Journal Article - Example
Pelargonio G, Fogel RI, Knilans TK, Prystowsky EN: Late occurence of heart block after radiofrequency catheter ablation of the septal region: Clinical follow-up and outcome. J Cardiovasc Electrophysiol 2001; 12:56-60.
(b) Chapter in Book with Different Author and Editor - Example
Myerburg RJ, Mitrani R, Interian A, Castellanos A: Identification of risk or cardiac arrest and sudden death in athletes. In Estes, NAM, Salem DM, Wang PJ eds: Sudden Cardiac Death in the Athlete. Armonk, NY: Futura Publishing Co., 1999, pp, 25-27.
(c) Book with Identical Author and Editor - Example
Klein GJ, Prystowsky EN: Clinical Electrophysiology Review. New York: McGraw-Hill, 1997, p. 83.
· Figures/Illustrations: Each figure must have legend explaining all abbreviations and symbols appearing in the illustration. Label each figure to match the corresponding number in the manuscript text and in the Figure Legend. Figures formatted as JPG, PDF, PPT, and PS files are acceptable for the initial stages of manuscript review; however, corresponding figures for manuscripts accepted for publication must be furnished in either TIFF or EPS file format. Arrangements for color reproductions must be made with the publisher before publication. Written permission from publishers for any figure previously published should be provided with the original submission. Photographs in which a patient or other person is identifiable must have written permission from that person.
· Tables: Tables must be self-explanatory and supplement, not duplicate, the text. Number brief titles in Arabic numerals according to the order they are mentioned in the text. Each table should be designed for economy of space and readability. Notes designated in the tables and all abbreviations should be defined in a footnote. Abbreviations should be identified in alphabetical order. Footnote designations should be used in the following order: *, +, ‡, §.
· Acknowledgments: Please provide directly on your manuscript complete funding details, including funding body name and grant number, for all relevant grants used to support the research on which your article is based.
PUBLICATION
Authors whose manuscripts are accepted for publication must complete and return the Copyright Assignment and Conflict of Interest forms before the manuscript can be sent to the publisher for production. Both of these forms can be found at http://mc.manuscriptcentral.com/cts by following the 'Instructions and Forms' link at the top of the page. Original, signed documents should be mailed to the Editorial Office. Please note the following:
· One Copyright Assignment form should be signed by all authors. If distance prohibits this requirement from being fulfilled, the form can be signed by the first author, who takes responsibility for informing the other authors of the copyright terms.
· A separate Conflict of Interest Form must be signed by each author. CTS requires full disclosure of any and all financial or other relations as they relate to the authors and the data in the manuscript.
Authors of accepted manuscripts will be able to review their page proofs via an online posting site. Corresponding authors will be notified via email when their page proofs are ready. Changes at the proofing stage are limited to typographical errors or errors in the presentation of data. These changes can be made only if the material is returned to the production editor within 24 hours after the page proofs have been posted.
POLICIES/LETTER OF SUBMISSION
Original Manuscripts: Manuscripts submitted must be original, with no portion under simultaneous consideration for publication elsewhere or previously published, except for an abstract of fewer than 400 words. All authors should have made an important contribution to the study and should be thoroughly familiar with the primary data. All authors are responsible for the contents and must have read and approved the manuscript and conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals published in the Annals of Internal Medicine 1997: 126:36-37. (See the online version at http://www.icmje.org/index.html.)
Experimental Ethics: Studies involving experimental animals or humans must conform to the guiding principles of the Declaration of Helsinki, and human subjects must have given informed consent of a study that has been approved by the Institutional Committee on Human Research at the author's institution. Please provide sex-specific data, when appropriate, in describing outcomes of epidemiologic analyses or clinical trials; or specifically state that no sex-based differences were present. Any financial or other relations must be disclosed. (For more information on copyright and conflict of interest, see Publication section.) Letters of submission must include affirmation of all the information mentioned above.
Inactivity: Manuscripts inactive for more than one year will be considered withdrawn.
Author Material Archive Policy: Please note that unless specifically requested, Wiley-Blackwell will dispose of hard copy or electronic material 2 months after publication.
Subscription Requests and Other Business Communications:
Please contact: Wiley-Blackwell Journal Customer Services, 350 Main Street, Malden, MA 02148-5018 USA. Phone: 1-800-835-6770 or +1-781-388-8599; Fax: +1-781-388-8232; Email: cs-journals@wiley.com.
NEW: Online production tracking is now available for your article through Wiley-Blackwell's Author Services. Author Services enables authors to track articles--once they have been accepted--through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the production editor to check on progress. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission, and more.
Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.
Editorial Board
Editor-in-Chief
Arthur M. Feldman, MD, PhD, Thomas Jefferson University
Deputy Editor
Scott A. Waldman, MD, PhD, Thomas Jefferson University
Executive Editors
Joseph M. Ahearn, MD, Allegheny Singer Research Institute, West Penn Allegheny Health System
Lars Berglund, MD, PhD, University of California-Davis Clinical and Translational Science Center
Jerrold J. Ellner, MD, Boston University; Boston Medical Center
Ronald E. Gress, MD
Terry Hyslop, PhD, Jefferson University
Walter J. Koch, PhD, Jefferson Medical College
Michael Levine, MD, University of Pennsylvania
Harry P. Selker, MD, MSPH, Tufts Clinical and Translational Science Institute; Tufts Medical Center
Andre Terzic, MD, PhD, Mayo Clinic
CTSA Editor
Steven E. Reis, MD, Clinical and Translational Science Institute, University of Pittsburgh
APOR Editor
Charles W. Flexner, MD, Johns Hopkins Hospital
Associate Editors
Bruce S. Bochner, MD, Johns Hopkins University School of Medicine
Joseph V. Bonventre, MD, PhD, Brigham & Women's Hospital; Harvard Medical School
Paul F. Bray, MD, Jefferson Medical College
Michael R. Bristow, MD, PhD, University of Colorado Health Services Center
Judy H. Cho, MD, Yale University
Harry C. Dietz III, MD, Johns Hopkins University, School of Medicine
Adrian Dobs, MD, MHS, Johns Hopkins University School of Medicine
Raymond N. Dubois, Jr., MD, PhD, University of Texas MD Anderson Cancer Center
Serpil C. Erzurum, MD, Cleveland Clinic Foundation
Eric R. Fearon, MD, PhD, University of Michigan
Thomas L. Force, MD, Jefferson Medical College
Samuel E. Gandy, MD, PhD, Mt. Sinai School of Medicine
Mark W. Geraci, MD, University of Colorado Health Sciences Center
Barry Goldstein, MD, PhD, Merck Research Laboratories
Elizabeth M. Jaffee, MD, The Sidney Kimmel Cancer Center at Johns Hopkins
Paul Kessler, MD, Nabi Biopharmaceuticals
Bruce C. Kone, MD, University of Florida College of Medicine
Steven W. Ryder, MD, Astellas Pharma US
Raymond L. Woosley, MD, PhD, The Critical Path Institute
Vincent V. Yang, MD, PhD, Emory University School of Medicine
Neal S. Young, MD
Advisory Board
Edward J. Benz Jr., MD, Dana-Farber Cancer Institute
Ferid Murad, MD, PhD, The University of Texas
Arthur H. Rubenstein, MBBCh, University of Pennsylvania
Myron L. Weisfeldt, MD, John Hopkins University School of Medicine
Editorial Board
Francois M. Abboud, MD, University of Iowa Carver College of Medicine
Charles S. Abrams, MD, University of Pennsylvania
N. Franklin Adkinson Jr., MD, Johns Hopkins University
Anupam Agarwal, MD, University of Alabama at Birmingham
Frank A. Anania, MD, Emory University School of Medicine
Piero Anversa, MD, Harvard University School of Medicine
Eiichi Araki, MD, PhD, Kumamoto University School of Medicine, Japan
Andrew Arnold, MD, University of Connecticut
Carlos L. Arteaga, MD, Vanderbilt University
George F. Atweh, MD, Mount Sinai School of Medicine
Grover C. Bagby, MD, Oregon Health and Science University
Christie M. Ballantyne, MD, Baylor College of Medicine
Lewis C. Becker, MD, Johns Hopkins University School of Medicine
Diane M. Becker, RN, MPH, ScD, Johns Hopkins University School of Medicine
Ivor J. Benjamin, MD, University of Utah Health Sciences Center
Craig L. Bennett, PhD, University of Washington
Joel S. Bennett, MD, University of Pennsylvania
Monica Bessler, MD, PhD, Washington University
John Paul Bilezikian, MD, College of Physicians and Surgeons, Columbia University
David G. Binion, MD, Medical College of Wisconsin
Terrence F. Blaschke, MD, Stanford University School of Medicine
Bruce Blazar, MD, University of Minnesota
Jeffrey A. Bluestone, PhD, University of California, San Francisco
Robert A. Bonomo, MD, Case Western University
Robert A. Brodsky, MD, Johns Hopkins University School of Medicine
Todd T. Brown, MD, PhD, Johns Hopkins University
F. Charles Brunicardi, MD, Baylor College of Medicine
John C. Burnett Jr., MD, Mayo Clinic
Joseph S. Camardo, MD, Wyeth Research
Michael Camilleri, MD, Mayo Clinic
Fabio Candotti, MD, National Institutes of Health
John M. Carethers, MD, University of California, San Diego
Mario Castro, MD, MPH, Washington University School of Medicine
Lawrence Chan, MBBS, DSc, Baylor College of Medicine
Nelson J. Chao, MD, Duke University
Gautam Chaudhuri, MD, PhD, David Geffen School of Medicine at University of California
Bruce D. Cheson, MD, Georgetown University
Joseph Y. Cheung, MD, PhD, Jefferson Medical College
Kathleen R. Cho, MD, University of Michigan Medical School
Suzy A. Comhair, PhD, Cleveland Clinic
Nancy Connell, PhD, University of Medicine and Dentistry of New Jersey
Carlos Cordon-Cardo, MD, PhD, Columbia University
Edward D. Crandall, MD, PhD, Keck School of Medicine, University of Southern California
Ronald G. Crystal, MD, Weill Cornell Medical College/New York Presbyterian Hospital
David T. Curiel, MD, PhD, University of Alabama at Birmingham
Mary Cushman, MD, University of Vermont
Chi Van Dang, MD, PhD, Johns Hopkins University School of Medicine
Pamela Davis, MD, PhD, Case Western University
Stefano Del Prato, MD, University of Pisa
Willard Dere, MD, Amgen
John F. DiPersio, MD, PhD, Washington University in St. Louis
Gerald W. Dorn II, MD, University of Cincinnati
Gregory P. Downey, MD, National Jewish Medical and Research Center
Jonathan A. Dranoff, MD, Yale University
Helmut Drexler, MD, Medizinische Hochschule Hannover, Germany
Marc K. Drezner, MD, University of Wisconsin
Steven M. Dubinett, MD, David Geffen School of Medicine at University of California
Raed Dweik, MD, Cleveland Clinic
Robert H. Eckel, MD, University of Colorado at Denver and Health Sciences Center
Andrea D. Eckhart, PhD, Jefferson Medical College
Merrill J. Egorin, MD, University of Pittsburgh Cancer Institute
N. Tony Eissa, MD, Baylor College of Medicine
David J. Erle, MD, University of California, San Francisco
Toren Finkel, MD, National Institutes of Health
Timothy P. Flanigan, MD, Brown University
Jonathan A. Fletcher, MD, Harvard Medical School
Andrew P. Fontenot, MD, University of Colorado at Denver and Health Sciences Center
John N. Forrest, Jr., MD, Yale University
David A. Fox, MD, University of Michigan
Benjamin M. Gaston, MD, University of Virginia School of Medicine
Gregory G. Germino, MD, Johns Hopkins University School of Medicine
Stanton L. Gerson, MD, Case Western Reserve University School of Medicine
Gary S. Gilkeson, MD, University of South Carolina
David Ginsburg, MD, University of Michigan
Ronald B. Goldberg, MD, University of Miami
Steven A. Goldman, MD, PhD, University of Rochester Medical Center
Pascal J. Goldschmidt, MD, University of Miami Miller School of Medicine
Glenn Gormley, MD, PhD, Novartis Pharmaceuticals Corporation
Jorg J. Goronzy, MD, PhD, Emory University School of Medicine
Raj K. Goyal, MD, Harvard Medical School
Theresa A. Guise, MD, University of Virginia
William C. Hahn, MD, PhD, Harvard Medical School
H. Kirk Hammond, MD, University of California, San Diego
Rochelle Hanley, MD, QuatRx Pharmaceuticals
Tina V. Hartert, MD, MPH, Vanderbilt University School of Medicine
Gerd Hasenfuss, MD, Georg-August University, Heart Center, Göttingen, Germany
Craig W. Hendrix, MD, Johns Hopkins University
Kevan Herold, MD, Yale University
Ray E. Hershberger, MD, University of Miami Miller School of Medicine
Jay L. Hess, MD, PhD, University of Michigan Medical School
Sally L. Hodder, MD, University of Medicine and Dentistry of New Jersey
Michael J. Holtzman, MD, Washington University School of Medicine
Steven R. Houser, PhD, Temple University School of Medicine
Gary W. Hunninghake, MD, University of Iowa Carver College of Medicine
Sin-Ho Jung, PhD, Duke University School of Medicine
Steven E. Kahn, MD, ChB, University of Washington
Naftali Kaminski, MD, University of Pittsburgh School of Medicine
David A. Kass, MD, Johns Hopkins University School of Medicine
Robert L. Keith, MD, University of Colorado Health Sciences Center
Philip A. Kern, MD, University of Kentucky
Fadlo R. Khuri, MD, Emory University School of Medicine
Landon S. King, MD, Johns Hopkins School of Medicine
Masafumi Kitakaze, MD, PhD, National Cardiovascular Center
Richard N. Kitsis, MD, Albert Einstein College of Medicine
Thomas R. Kleyman, MD, University of Pittsburgh
Alisa Erika Koch, MD, University of Michigan
Donald E. Kohan, MD, PhD, University of Utah
Richard Koup, MD, National Institutes of Health
Markku Laakso, MD, University of Kuopio, Finland
Donald W. Landry, MD, PhD, Columbia University
Andrew D. Leavitt, MD, University of California, San Francisco
Michael M. Lederman, MD, Case Western Reserve University
Lawrence A. Leiter, MD, University of Toronto
Jonathan D. Licht, MD, Northwestern University
Rodger A. Liddle, MD, Duke University Medical Center
Stephen B. Liggett, MD, University of Maryland School of Medicine
Michael P. Lisanti, MD, PhD, Thomas Jefferson University
Peter P. Liu, MD, Toronto General Hospital
Massimo F. Loda, MD, Harvard Medical School
Barry London, MD, PhD, University of Pittsburgh
Thomas J. Lynch, MD, Massachusetts General Hospital
Douglas L. Mann, MD, Baylor College of Medicine
Simeon Margolis, MD, PhD, Johns Hopkins University
Kenneth B. Margulies, MD, University of Pennsylvania
W. Stratford May Jr., MD, PhD, University of Florida
Francis X. McCormack, MD, University of Cincinnati School of Medicine
Joseph M. McCune, MD, PhD, University of California, San Francisco
Christine E. McLaren, PhD, University of California, Irvine
Vallerie V. McLaughlin, MD, University of Michigan
Elizabeth M. McNally, MD, PhD, University of Chicago
Shlomo Melmed, MD, Cedars-Sinai Medical Center
J. Philip Miller, Washington University School of Medicine
William E. Mitch, MD, Baylor College of Medicine
Laurence Morel, MD, PhD, University of Florida
Motomi Mori, PhD, Oregon Health and Science University
Elizabeth Murphy, PhD, National Heart, Blood, and Lung Institute, National Institutes of Health
Robert S. Negrin, MD, Stanford University
Eric G. Neilson, MD, Vanderbilt University
Lei Nie, PhD, Georgetown University
Joyce C. Niland, PhD, City of Hope Cancer Center
Paul W. Noble, MD, Duke University
Drew M. Pardoll, MD, PhD, Johns Hopkins University
R. Stokes Peebles, MD, Vanderbilt University
Richard M. Peek Jr., MD, Vanderbilt University
David H. Perlmutter, MD, University of Pittsburgh
Marc L. Peters-Golden, MD, University of Michigan
Steven Piantadosi, MD, PhD, Johns Hopkins University
Robert Michael Poole, MD, Wyeth Research
Chaim Putterman, MD, Albert Einstein College of Medicine
Reed E. Pyeritz, MD, PhD, University of Pennsylvania
Richard John Quigg Jr., MD, University of Chicago
Hamid Rabb, MD, Johns Hopkins University
Marlene Rabinovitch, MD, Stanford University
Daniel J. Rader, MD, University of Pennsylvania
Pranela Rameshwar, PhD, University of Medicine and Dentistry of New Jersey
A. Koneti Rao, MD, Temple University School of Medicine
Mark J. Ratain, MD, University of Chicago
Stanley R. Riddell, MD, University of Washington
Renee Ridzon, MD, Gates Foundation
Basil Rigas, MD, DSc, State University of New York at Stony Brook
Jeffrey Robbins, PhD, Cincinnati Children's Hospital Medical Center
Howard A. Rockman, MD, Duke University School of Medicine
Jesse Roman, MD, Emory University
Anthony Rosenzweig, MD, Beth Israel Deaconess Medical Center
Michael S. Saag, MD, University of Alabama
Robert A. Salata, MD, Case Western Reserve University, University Hospitals Case Medical Center
Padmini Salgame, PhD, University of Medicine and Dentistry of New Jersey/New Jersey Medical School
Reijo Salonen, MD, PhD, Orion Corporation
Roberto Salvatori, MD, Johns Hopkins University
Jeff M. Sands, MD, Emory University
David T. Scadden, MD, Harvard Medical School/Massachusetts General Hospital
Michael D. Schneider, MD, Baylor College of Medicine
Stanley G. Schultz, MD, University of Texas Medical School at Houston
Alan L. Schwartz, MD, PhD, Washington University School of Medicine
Françoise Seillier-Moiseiwitsch, PhD, Georgetown University
Gregg L. Semenza, MD, PhD, Johns Hopkins University
Nicholas J. Shaheen, MD, University of North Carolina School of Medicine
Reza Shaker, MD, Medical College of Wisconsin
Yongzhao Shao, PhD, New York University School of Medicine
Dean Sheppard, MD, University of California, San Francisco
Steven E. Shoelson, MD, PhD, Harvard University
Gerald I. Shulman, MD, PhD, Yale University
Eric Sibley, MD, PhD, Stanford University
Richard Siegel, MD, PhD, National Institutes of Health
Edwin K. Silverman, MD, PhD, Brigham and Women's Hospital Channing Laboratory
Gregg J. Silverman, MD, University of California, San Diego
Shanthi V. Sitaraman, MD, PhD, Emory University
George Sopko, MD, MPH, National Heart, Lung, and Blood Institute, National Institutes of Health
Rhonda F. Souza, MD, University of Texas Southwestern
Jonathan S. Stamler, MD, Duke University
Gary L. Stiles, MD, Wyeth Pharmaceuticals
Robert M. Strieter, MD, University of Virginia
Michael Stumvoll, MD, PhD, University of Leipzig
Marilyn J. Telen, MD, Duke University
Lance Terada, MD, University of Texas Southwestern
Zara Toossi, MD, Case Western Reserve University
Eric J. Topol, MD, Scripps Health
Jeffrey A. Towbin, MD, Baylor College of Medicine
Bruce C. Trapnell, MD, MS, University of Cincinnati College of Medicine
Rubin M. Tuder, MD, Johns Hopkins University
David J. Tweardy, MD, Baylor College of Medicine
Jouni J. Uitto, MD, PhD, Jefferson Medical College
Paul J. Utz, MD, Stanford University
Judith A. Voynow, MD, Duke University
Susan M. Wall, MD, Emory University School of Medicine
Gary S. Wand, MD, Johns Hopkins University School of Medicine
David G. Warnock, MD, University of Alabama
Ethan Weiner, MD, Pfizer Global Research
Lee S. Weinstein, MD, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
William S. Weintraub, MD, Christiana Hospital
Rebecca G. Wells, MD, University of Pennsylvania
David P. Westfall, MD, University of Nevada, Reno
R. Sanders Williams, MD, Duke University
James K. V. Willson, MD, University of Texas Southwestern Medical Center at Dallas
Jane Y. Wu, MD, PhD, Northwestern University School of Medicine
Tsutomu Yamazaki, MD, PhD, The University of Tokyo
Joseph Zabner, MD, The University of Iowa
Mark L. Zeidel, MD, Harvard Medical School
|
